Hepatitis B - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatitis B virus (HBV) enters hepatocytes and integrates into host DNA, prompting immune-mediated liver cell damage as cytotoxic T cells attack infected hepatocytes, leading to inflammation and liver injury.

• Secondary mechanism: Persistent HBV infection can lead to chronic inflammation, causing fibrosis through activation of hepatic stellate cells, which secrete extracellular matrix proteins, culminating in cirrhosis.

• Key complication: Chronic HBV infection and resultant cirrhosis significantly increase the risk of hepatocellular carcinoma due to ongoing inflammation, cellular turnover, and integration of viral DNA, promoting oncogenic mutations.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Chronic Hepatitis B, cirrhosis, type 2 diabetes, hypertension

• Current medications: Tenofovir, metformin, lisinopril, propranolol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and jaundice

• Key symptoms: Fatigue, nausea, vomiting, ascites, confusion, edema

• Vital signs: Blood pressure 85/50 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101.4°F, oxygen saturation 88% on room air

Section 1

As the healthcare team begins the initial assessment of the 45-year-old male patient, they note his severe distress and altered mental status, indicative of hepatic encephalopathy. His abdomen is distended with shifting dullness on percussion, confirming significant ascites. Spider angiomas are visible on his upper body, further suggesting advanced liver disease. The skin is icteric, and scleral jaundice is pronounced. On auscultation, the breath sounds are diminished at the bases, likely due to pleural effusion. His extremities exhibit pitting edema, and there is evidence of muscle wasting, consistent with malnutrition.

Laboratory results reveal a critically elevated bilirubin level of 18 mg/dL, with an INR of 2.5, indicating coagulopathy. The patient's albumin is low at 2.1 g/dL, exacerbating fluid imbalances and contributing to edema. Liver function tests show an AST of 320 U/L and ALT of 290 U/L, reflecting ongoing hepatic inflammation and injury. Renal function is compromised, with a serum creatinine of 2.2 mg/dL, suggesting hepatorenal syndrome. Arterial blood gas analysis indicates metabolic acidosis with a pH of 7.28, likely due to lactic acidosis from poor tissue perfusion and hepatic insufficiency.

In response to these findings, the clinical team initiates an aggressive management plan, including diuretics for ascites, lactulose to reduce ammonia levels, and careful fluid resuscitation to stabilize hemodynamics. They also prioritize supplemental oxygen therapy to address hypoxemia and consider initiating antibiotics to manage potential spontaneous bacterial peritonitis. Despite these interventions, the patient's condition remains tenuous, necessitating close monitoring for further complications, such as variceal bleeding or progression to multi-organ failure, which could significantly impact his prognosis and require advanced critical care strategies.

Section 2

As the clinical team continues to monitor the patient, they notice a change in his mental status. The patient's level of consciousness fluctuates, and he becomes increasingly lethargic, raising concerns about worsening hepatic encephalopathy. Despite the administration of lactulose, the patient's ammonia levels remain elevated at 95 µmol/L, suggesting inadequate response to treatment. His vital signs reveal a blood pressure of 88/60 mmHg, heart rate of 112 bpm, and respiratory rate of 26 breaths per minute, indicating possible hemodynamic instability. Oxygen saturation has dropped to 88% on supplemental oxygen, suggesting worsening hypoxemia. These changes prompt a reassessment of the patient's condition and a need to consider further diagnostic imaging and laboratory investigations.

A repeat ultrasound of the abdomen is performed, which shows an increase in ascitic fluid volume and signs of portal hypertension, with dilated portal veins. Additionally, there is evidence of splenomegaly, which may contribute to hypersplenism and worsening cytopenias. The team suspects spontaneous bacterial peritonitis (SBP) due to the patient's persistent fever and abdominal tenderness, necessitating an urgent diagnostic paracentesis. The ascitic fluid analysis reveals a polymorphonuclear leukocyte count of 350 cells/mm³, confirming the diagnosis of SBP. Blood cultures are also drawn to identify any systemic infections that could be exacerbating his condition.

The patient's renal function continues to deteriorate, with serum creatinine rising to 2.8 mg/dL and a drop in urine output to 15 mL/hour, indicating progressive hepatorenal syndrome. The team decides to initiate terlipressin and albumin infusion to support renal perfusion while closely monitoring for any signs of variceal bleeding, given his coagulopathy and portal hypertension. The situation remains critical, as the team evaluates the need for transfer to a tertiary care center for potential liver transplant evaluation, recognizing that without significant intervention, the patient's prognosis is grim. This shift in the patient's status demands a reevaluation of priorities, focusing on stabilizing renal function, managing infection, and maintaining hemodynamic stability, all while preparing for the potential escalation of care.

Section 3

As the clinical team continues to manage the patient, they closely monitor for any changes in his condition, especially in response to the ongoing interventions. Despite the initiation of terlipressin and albumin, the patient's renal function shows minimal improvement. His serum creatinine remains elevated at 3.1 mg/dL, and his urine output has further decreased to 10 mL/hour. In addition to the renal challenges, the patient's hemodynamic status remains precarious. His blood pressure has dropped to 85/55 mmHg, with a heart rate of 118 bpm, suggesting worsening hypotension and compensatory tachycardia. His respiratory rate has increased to 30 breaths per minute, and oxygen saturation is now at 86% on a 50% Venturi mask, indicating escalating respiratory distress and the potential need for ventilatory support.

The team decides to perform a repeat arterial blood gas analysis, which reveals a pH of 7.31, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, suggestive of acute respiratory acidosis with severe hypoxemia. This finding, combined with the patient's mental status fluctuation and increasing lethargy, raises concerns about the progression of hepatic encephalopathy and potential acute respiratory failure. Given these complexities, the team also suspects the development of acute-on-chronic liver failure, which could further compromise the patient's already fragile state.

In light of these developments, the team prioritizes stabilizing the patient's respiratory status and plans for urgent intubation and mechanical ventilation to address the hypoxemia and respiratory acidosis. Concurrently, they reassess the patient's eligibility for transfer to a tertiary care center for liver transplant evaluation, as it becomes increasingly clear that his condition is deteriorating despite aggressive measures. The interdisciplinary team continues to collaborate, recognizing the need for rapid decision-making and the potential initiation of advanced therapies to prevent further decline.

Section 4

As the team prepares for urgent intubation, they notice a sudden change in the patient's condition. The patient becomes increasingly agitated and confused, requiring physical restraint to prevent self-harm. This acute mental status change prompts the team to evaluate for potential new complications, including intracranial events or worsening hepatic encephalopathy. A stat CT scan of the brain is performed, revealing no signs of hemorrhage or cerebral edema, but there is evidence of mild cerebral atrophy, consistent with chronic liver disease-related changes.

Meanwhile, laboratory results return, showing a significant worsening of the patient's coagulopathy. The international normalized ratio (INR) has increased to 3.5, and the platelet count has dropped to 40,000/μL, both indicative of advanced liver dysfunction and increasing the risk for bleeding complications. The patient's liver enzymes remain elevated, with aspartate aminotransferase (AST) at 350 U/L and alanine aminotransferase (ALT) at 300 U/L, while bilirubin levels have surged to 18 mg/dL, underscoring the severity of his hepatic impairment.

These findings necessitate immediate intervention to address the coagulopathy and plan for potential procedural complications during intubation. The team administers fresh frozen plasma and platelets to stabilize the patient's clotting function, while also considering the initiation of continuous renal replacement therapy (CRRT) to manage fluid overload and further support renal function. As the patient's clinical status becomes increasingly tenuous, the urgency for transfer to a tertiary care center for liver transplant evaluation intensifies, emphasizing the need for a cohesive, timely approach to manage this multifaceted clinical crisis.

Section 5

As the team administers fresh frozen plasma and platelets, they closely monitor the patient's vital signs and neurological status. Despite these interventions, the patient's blood pressure begins to trend downward, with readings dropping to 85/55 mmHg, and heart rate climbing to 125 beats per minute, indicating potential hemodynamic instability. The patient's respiratory rate increases to 30 breaths per minute, and oxygen saturation on high-flow nasal cannula decreases to 88%. These changes suggest a potential progression towards septic shock, possibly secondary to spontaneous bacterial peritonitis or another infectious process, given the patient's immunocompromised state due to liver failure.

In light of these developments, the team initiates broad-spectrum antibiotics empirically, while awaiting further diagnostic information. Blood cultures are obtained, and an abdominal ultrasound is performed, revealing moderate ascites with evidence of bacterial infection. Paracentesis is promptly conducted, and analysis of ascitic fluid shows a polymorphonuclear leukocyte count of 350 cells/mm³, confirming spontaneous bacterial peritonitis. This new complication necessitates aggressive management to prevent further deterioration.

The patient's tenuous condition requires a rapid, coordinated response. The critical care team discusses the need for vasopressor support to maintain hemodynamic stability and considers escalating care with the initiation of norepinephrine infusion. Simultaneously, they continue to advocate for expedited transfer to a tertiary care facility for liver transplant evaluation, understanding that definitive management of his acute liver failure and its complications hinges on the availability of a liver transplantation. The team remains vigilant, ready to adapt their strategy as they navigate this complex and rapidly evolving clinical scenario.